why NRX Pharmaceuticals Inc [NRXP] is a Good Choice for Investors After New Price Target of $3.17
NRX Pharmaceuticals Inc [NASDAQ: NRXP] slipped around -0.23 points on Tuesday, while shares priced at $0.44 at the close of the session, down -34.32%. The company report on March 12, 2024 at 7:49 AM that NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales. Initiative